Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01092975 · ClinicalTrials.gov registry record · Phase 1
Safety of Phenylephrine for Oral Mucositis Prevention
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01092975 is a Phase 1 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 1 participants.
The verdict
NCT01092975, a Phase 1 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if applying the drug phenylephrine to the inside of the mouth can be done safely and is tolerable to use in cancer patients receiving radiation to the Sub-mandibular lymph nodes.
Interventions
- DRUG phenylephrine solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01092975
The ClinicalTrials.gov registry entry for NCT01092975 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which phenylephrine solution is the first listed.
NCT01092975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01092975 about?
NCT01092975 is a clinical study titled "Safety of Phenylephrine for Oral Mucositis Prevention". The purpose of this study is to determine if applying the drug phenylephrine to the inside of the mouth can be done safely and is tolerable to use in cancer patients receiving radiation to the Sub-mandibular lymph nodes.
What is the current status of trial NCT01092975?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2010-03. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01092975?
The interventions under investigation include: phenylephrine solution (DRUG).
Who is sponsoring clinical trial NCT01092975?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.